… ’ performance status and the effect of chemotherapy on QOL in … good performance status
who receive additional palliative … most likely to benefit from palliative chemotherapy, our results …

… The benefit of palliative chemotherapy (PC) in patients with advanced solid tumors and
poor performance status (ECOG-PS) has not been prospectively validated, which makes …

… (CT) in the first line of treatment in patients with compromised performance status (PS), …
In the present study, palliative multiagent chemotherapy in poor performance status patients …

… suggest that palliative chemotherapy might benefit patients with mCRC and poor PS with
manageable toxicity. Patients with an ECOG PS of 3/4 who received chemotherapy generally …

… However, it provided complementary information about performance status and the effects
of PCT on patients. The proportion of patients older than 74 years receiving PCT in this study …

… This study showed that palliative chemotherapy is … with lower performance status are more
likely to receive palliative … informed potential side effects of palliative chemotherapy. The …

… Performance status had a major impact on survival. In our hands median survival for ECOG
PS 4 patients was extremely short (7 days). Patients showing an ECOG PS 3 also reached a …

… agents was excluded in order for the proper evaluation of the effect of the chemotherapy.
Patients’ performance status was graded according to ECOG criteria. The institutional review …

… clinician assessment of performance status in predicting both … patients receiving palliative
platinum-based chemotherapy or … , the positive impact of palliative chemotherapy is likely to be …

… performance status, which is considered a relative contraindication to cytotoxic chemotherapy.
… Thus, whether such care has positive effects on survival or quality of life is questionable …